Listed by the USPTO as ATKINSON, JOSHUA ALEXANDER
Tech Center 1600 • Art Units: 1612 1614 1624 1626
This examiner grants 52% of resolved cases
ATKINSON, JOSHUA ALEXANDER works in tech center 1600 and art unit 1612. The record covers 83 resolved cases, with a 51.8% allowance rate, a 27.5% interview lift, and a median of 1267 days to allowance. The limited record provides a useful directional view, while the allowance rate indicates that outcomes are mixed and the median timing supports extended prosecution planning.
The interview lift shows a meaningful association with recorded allowance outcomes. The listed companies are Syngenta AG, BASF SE, and L'Oréal. The firms are BakerHostetler, Knobbe, Martens, Olson & Bear, LLP, and MARSHALL, GERSTEIN & BORUN LLP. Practitioners may use interviews to clarify technical distinctions, then reinforce the agreed position through focused amendments and a complete written response.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18609750 | Oolitic Aragonite Beads and Methods Therefor | Non-Final OA | Nant Holdings IP, LLC |
| 17800747 | GLP-1 COMPOSITIONS AND USES THEREOF | Final Rejection | Novo Nordisk A/S |
| 18679874 | METHOD OF IMPROVING ANTIDANDRUFF EFFICACY BY USE OF A BOOSTER COMPOSITION IN COMBINATION WITH A HAIR CARE COMPOSITION | Non-Final OA | The Procter & Gamble Company |
| 18364891 | Click chemistry hydrogel with minimal swelling as a dural sealant and local delivery vehicle for recombinant proteins and other bioactive agents | Non-Final OA | Johns Hopkins University |
| 17999603 | NEW TRINEXAPAC-ETHYL MICROEMULSION COMPOSITIONS | Final Rejection | SYNGENTA CROP PROTECTION AG |
| 17633640 | 2-PHENOXY-PYRIMIDINE DERIVATIVES AS HERBICIDAL COMPOUNDS | Final Rejection | SYNGENTA CROP PROTECTION AG |
| 18280522 | NEW MICROPARTICLES CONTAINING ACTIVE SUBSTANCES | Non-Final OA | BASF SE |
| 18275042 | LIQUID HERBICIDAL COMPOSITIONS | Non-Final OA | BASF SE |
| 18405958 | Injectable Polymeric Biopharmaceutical Formulations | Non-Final OA | The Board of Trustees of the Leland Stanford Junior University |
| 18157953 | ORAL PHARMACEUTICAL COMPOSITION COMPRISING CARBAMATE COMPOUND AND PREPARATION METHOD THEREFOR | Final Rejection | SK BIOPHARMACEUTICALS CO., LTD. |
| 18262088 | POWDEROUS COMPOSITION (III) | Non-Final OA | DSM IP Assets B.V. |
| 18697559 | IONIC LIQUIDS FOR DRUG DELIVERY | Non-Final OA | PRESIDENT AND FELLOWS OF HARVARD COLLEGE |
| 18041479 | PHARMACEUTICAL COMPOSITION CONTAINING COCRYSTALS FOR ADDITIVE MANUFACTURING | Final Rejection | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM |
| 18719686 | COMPOSITION FOR LIGHTENING KERATIN FIBRES AND PROCESS FOR LIGHTENING KERATIN FIBRES USING THIS COMPOSITION | Non-Final OA | L'OREAL |
| 18716212 | SILICONE-FREE INVERSE EMULSION COMPRISING A C3 OR C4 ALKANEDIOL, GLYCEROL, A NONVOLATILE VEGETABLE OIL, A POLYGLYCERYL POLYRICINOLEATE SURFACTANT AND A VOLATILE ALKANE | Final Rejection | L'OREAL |
| 18683917 | OIL FOR COSMETICS, AND COSMETIC CONTAINING SAME | Final Rejection | NOF CORPORATION |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy51.8% of resolved applications examined by Joshua Alexander Atkinson were allowed (83 resolved cases), compared with 40.7% across Art Unit 1612 over the last five years.
This examiner's interview lift is +27.5 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Joshua Alexander Atkinson took 1,267 days on average from filing to allowance.
Joshua Alexander Atkinson examines applications in Art Unit 1612 in Tech Center 1600 (Biotechnology & Pharmaceuticals).
